rs1887197983

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_174976.2(ZDHHC22):​c.422T>C​(p.Met141Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000069 in 1,449,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000069 ( 0 hom. )

Consequence

ZDHHC22
NM_174976.2 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.23

Publications

0 publications found
Variant links:
Genes affected
ZDHHC22 (HGNC:20106): (zinc finger DHHC-type palmitoyltransferase 22) Predicted to enable protein-cysteine S-palmitoyltransferase activity. Involved in protein localization to plasma membrane and protein palmitoylation. Located in Golgi apparatus; endoplasmic reticulum; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
TMEM63C (HGNC:23787): (transmembrane protein 63C) Enables calcium activated cation channel activity. Involved in cation transport. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. Biomarker of focal segmental glomerulosclerosis. [provided by Alliance of Genome Resources, Apr 2022]
TMEM63C Gene-Disease associations (from GenCC):
  • spastic paraplegia 87, autosomal recessive
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19899678).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZDHHC22NM_174976.2 linkc.422T>C p.Met141Thr missense_variant Exon 2 of 3 ENST00000319374.4 NP_777636.2 Q8N966
ZDHHC22NM_001364172.1 linkc.422T>C p.Met141Thr missense_variant Exon 2 of 3 NP_001351101.1
ZDHHC22XM_011536661.3 linkc.422T>C p.Met141Thr missense_variant Exon 2 of 3 XP_011534963.1 Q8N966

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZDHHC22ENST00000319374.4 linkc.422T>C p.Met141Thr missense_variant Exon 2 of 3 1 NM_174976.2 ENSP00000318222.4 Q8N966
ENSG00000259164ENST00000557752.1 linkn.136+33473A>G intron_variant Intron 2 of 5 5 ENSP00000456507.1 H3BS24
TMEM63CENST00000557408.5 linkc.-237+22475A>G intron_variant Intron 1 of 3 4 ENSP00000450879.1 G3V2V1
ZDHHC22ENST00000555389.1 linkc.*93T>C downstream_gene_variant 4 ENSP00000451337.1 G3V3N3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000690
AC:
10
AN:
1449066
Hom.:
0
Cov.:
31
AF XY:
0.00000556
AC XY:
4
AN XY:
719354
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33292
American (AMR)
AF:
0.00
AC:
0
AN:
42524
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25886
East Asian (EAS)
AF:
0.0000511
AC:
2
AN:
39152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83776
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52492
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5754
European-Non Finnish (NFE)
AF:
9.04e-7
AC:
1
AN:
1106182
Other (OTH)
AF:
0.000100
AC:
6
AN:
60008
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 31, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.422T>C (p.M141T) alteration is located in exon 2 (coding exon 1) of the ZDHHC22 gene. This alteration results from a T to C substitution at nucleotide position 422, causing the methionine (M) at amino acid position 141 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
18
DANN
Benign
0.80
DEOGEN2
Benign
0.056
T
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.28
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.61
T
M_CAP
Benign
0.0045
T
MetaRNN
Benign
0.20
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.17
N
PhyloP100
4.2
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.087
Sift
Benign
0.18
T
Sift4G
Benign
0.13
T
Polyphen
0.0
B
Vest4
0.47
MutPred
0.59
Loss of stability (P = 0.007);
MVP
0.13
MPC
0.52
ClinPred
0.12
T
GERP RS
1.8
Varity_R
0.063
gMVP
0.76
Mutation Taster
=60/40
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1887197983; hg19: chr14-77605660; API